<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220620055227N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-09-03</date_registration>
      <primary_sponsor>Artesh University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of the effectiveness of neurofacial prolotherapy dextrose ontemporomandibular joint disorders</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the effectiveness of neurofacial prolotherapy dextrose ontemporomandibular joint disorders</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-09-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>34</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/64302</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Crossover, Purpose: Treatment, Randomization description: First, blocks of 4 are prepared, each block includes 2 patients for the control group and 2 patients for the intervention group. For example, in one block, the first two patients may be placed in the control group and the next two patients in the intervention group. And in another block, the patients may be divided one by one, Blinding description: Every patient is examined in the first visit by a doctor who is an expert in the field of the disease and is unaware of the patient's therapeutic intervention group, and the follow-up and recording of changes in the examination after the intervention is also recorded by the same doctor. It is the result of the intervention, it is requested not to talk about the treatment done. Also, the analysis of statistical data is done by an analyst who does not know the intervention group of patients.</study_design>
      <phase>1-2</phase>
      <hc_freetext>Temporomandibular joint pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The intended study will be conducted in patients referred to Imam Reza (AS) Hospital. The patients are divided into two intervention and control groups. In the prolotherapy group, the intervention is in the form of 1 session for each involved joint using a measuring needle. 30 and a 3 ml syringe with a combination of 0.75 ml of 50% dextrose, 0.75 ml of sterile distilled water and 1.5 ml of 2% lidocaine is injected in the area around the temporomandibular joint and in the neurofascial path under ultrasound guidance. Intervention 2: Control group: under 10 regular sessions of physiotherapy of the temporomandibular joint area involved by the routine modality of physiotherapy in each session: heat therapy with IR light for 10 minutes, electrotherapy by TENS with an analgesic approach for 5 minutes, US with pulse and high frequency method for 5 minutes. All Therapeutic modalities are the creation of a modern medical engineering company.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sepanta Hatam</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>AJA university of medical science Etemad zade Ave, Fatemi Street, Amirabad</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1411718541</zip>
        <telephone>+98 21 8609 6350</telephone>
        <email>sepanta3v@yahoo.com</email>
        <affiliation>Artesh University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Sepanta Hatam</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>AJA university of medical science Etemad zade Ave, Fatemi Street, Amirabad</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1411718541</zip>
        <telephone>+98 21 8609 6350</telephone>
        <email>sepanta3v@yahoo.com</email>
        <affiliation>Artesh University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>All patients with temporomandibular joint disorders
Informed consent of the patient and willingness to participate in the study</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Active infection in the temporomandibular joint
Pregnancy and breastfeeding
History of surgery in the joint itself
A history of fracture or dislocation in the temporomandibular joint
History of tumor and malignancy in place
Coagulation disorders
Use of systemic corticosteroid drugs in the last month
diabetes
Systemic rheumatological disorders
Taking anticoagulant drugs</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The intended study will be conducted in patients referred to Imam Reza (AS) Hospital. The patients are divided into two intervention and control groups. In the prolotherapy group, the intervention is in the form of 1 session for each involved joint using a measuring needle. 30 and a 3 ml syringe with a combination of 0.75 ml of 50% dextrose, 0.75 ml of sterile distilled water and 1.5 ml of 2% lidocaine is injected in the area around the temporomandibular joint and in the neurofascial path under ultrasound guidance.</i_keyword>
      <i_keyword>Control group: under 10 regular sessions of physiotherapy of the temporomandibular joint area involved by the routine modality of physiotherapy in each session: heat therapy with IR light for 10 minutes, electrotherapy by TENS with an analgesic approach for 5 minutes, US with pulse and high frequency method for 5 minutes. All Therapeutic modalities are the creation of a modern medical engineering company.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain intensity based on visual analog scale after intervention. Timepoint: At the beginning of the study (before the start of the intervention) and 1 month, then 3 and 6 months after the intervention. Method of measurement: Visual analog scale (VAS) questionnaire.</prim_outcome>
      <prim_outcome>Severity of functional impairment based on visual analog scale after intervention. Timepoint: At the beginning of the study (before the start of the intervention) and 1 month, then 3 and 6 months after the intervention. Method of measurement: Visual analog scale (VAS) questionnaire.</prim_outcome>
      <prim_outcome>The maximum distance between teethUpper and lower bite that can be done by the patientIt can be done without causing pain, after the intervention.Community Verified icon. Timepoint: At the beginning of the study (before the start of the intervention) and 1 month, then 3 and 6 months after the intervention. Method of measurement: Ruler in mm.</prim_outcome>
      <prim_outcome>Additional sound found during opening and closing of the mouth in the temporomandibular joint. Timepoint: At the beginning of the study (before the start of the intervention) and 1 month, then 3 and 6 months after the intervention. Method of measurement: During the doctor's examination.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Artesh University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-06-19</approval_date>
        <contact_name>Research Ethics Committees of AJA University of Medical Sciences</contact_name>
        <contact_address>No. 15, azadeh Ave., South Bahar street., west fedos blvd Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
